Funicular Funds, LP

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Jacob Ma-Weaver, Managing Member of the General Partner
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Funicular Funds, LP

Form 4 holding Other*, 10%+ Owner

ARCA biopharma, Inc.

Security class
Common Stock
Shares / value
4,000,452
Estimated value
$10,001,130
Report date
16 Dec 2022
Price
$2.50
Ownership
Direct
Form 4 holding Other*, 10%+ Owner

ARCA biopharma, Inc.

Security class
Common Stock
Shares / value
2,580,452
Estimated value
$6,451,130
Report date
01 Jul 2022
Price
$2.50
Ownership
By Funicular Funds, LP
Form 4 holding Other*, 10%+ Owner

ARCA biopharma, Inc.

Security class
Common Stock
Shares / value
2,580,452
Estimated value
$6,451,130
Report date
01 Jul 2022
Price
$2.50
Ownership
By the Funicular Fund, LP
Form 4 holding 10%+ Owner

MEI Pharma, Inc.

Security class
Common Stock
Shares / value
611,440
Estimated value
$4,280,080
Report date
20 Oct 2023
Price
$7.00
Ownership
By Funicular Funds, LP
Form 4 holding 10%+ Owner

SYNLOGIC, INC.

Security class
Common stock
Shares / value
3,312,219
Estimated value
$1,907,176
Report date
09 Feb 2024
Price
$0.5758
Ownership
Direct
Form 4 holding Other*, 10%+ Owner

ARCA biopharma, Inc.

Security class
Stock Option (right to buy)
Shares / value
18,000
Estimated value
Report date
15 Dec 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*, 10%+ Owner

ARCA biopharma, Inc.

Security class
Put Option
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
By the Funicular Fund
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*, 10%+ Owner

ARCA biopharma, Inc.

Security class
Put Option
Shares / value
0
Estimated value
Report date
16 Dec 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

MEI Pharma, Inc.

Security class
Put Option (obligation to buy)
Shares / value
0
Estimated value
Report date
20 Oct 2023
Price
Ownership
By Funicular Funds, LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Funicular Funds, LP

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .